Medical Care
Global Diabetic Gastroparesis Market Research Report 2025
- Jul 08, 25
- ID: 348822
- Pages: 85
- Figures: 89
- Views: 18
The global market for Diabetic Gastroparesis was valued at US$ 2302 million in the year 2024 and is projected to reach a revised size of US$ 3310 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the vagus nerve, in cases where the blood glucose levels remain high over a longer duration. Diabetes gastroparesis is usually diagnosed with the help of imaging techniques such as ultrasound and x-ray, which is accompanied by the intake of radio isotopic meals containing barium, or using hematological / blood tests, and endoscopic techniques. There has been a marked increase in the prevalence of diabetes, especially in the developing countries, including China, India, Brazil, and some other Asian countries, leading to increasing incidence of diabetic neuropathy and consequent rise in diabetes gastroparesis around the world.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetic Gastroparesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Gastroparesis.
The Diabetic Gastroparesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetic Gastroparesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Gastroparesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Sumitomo Dainippon Pharma
Abbott Laboratories
Boston Scientific Corporation
C. R. Bard, Inc
Janssen Global Services, LLC
Alfasigma SpA
Evoke Pharma
Cadila Pharmaceuticals
Sanofi
Teva Pharmaceutical Industries Ltd
Pfizer
Vanda Pharmaceuticals
Allergan
Segment by Type
Drugs
Surgical Treatment Products
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Gastroparesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the vagus nerve, in cases where the blood glucose levels remain high over a longer duration. Diabetes gastroparesis is usually diagnosed with the help of imaging techniques such as ultrasound and x-ray, which is accompanied by the intake of radio isotopic meals containing barium, or using hematological / blood tests, and endoscopic techniques. There has been a marked increase in the prevalence of diabetes, especially in the developing countries, including China, India, Brazil, and some other Asian countries, leading to increasing incidence of diabetic neuropathy and consequent rise in diabetes gastroparesis around the world.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetic Gastroparesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Gastroparesis.
The Diabetic Gastroparesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetic Gastroparesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Gastroparesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Sumitomo Dainippon Pharma
Abbott Laboratories
Boston Scientific Corporation
C. R. Bard, Inc
Janssen Global Services, LLC
Alfasigma SpA
Evoke Pharma
Cadila Pharmaceuticals
Sanofi
Teva Pharmaceutical Industries Ltd
Pfizer
Vanda Pharmaceuticals
Allergan
Segment by Type
Drugs
Surgical Treatment Products
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Gastroparesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Gastroparesis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Surgical Treatment Products
1.3 Market by Application
1.3.1 Global Diabetic Gastroparesis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Gastroparesis Market Perspective (2020-2031)
2.2 Global Diabetic Gastroparesis Growth Trends by Region
2.2.1 Global Diabetic Gastroparesis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diabetic Gastroparesis Historic Market Size by Region (2020-2025)
2.2.3 Diabetic Gastroparesis Forecasted Market Size by Region (2026-2031)
2.3 Diabetic Gastroparesis Market Dynamics
2.3.1 Diabetic Gastroparesis Industry Trends
2.3.2 Diabetic Gastroparesis Market Drivers
2.3.3 Diabetic Gastroparesis Market Challenges
2.3.4 Diabetic Gastroparesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Gastroparesis Players by Revenue
3.1.1 Global Top Diabetic Gastroparesis Players by Revenue (2020-2025)
3.1.2 Global Diabetic Gastroparesis Revenue Market Share by Players (2020-2025)
3.2 Global Diabetic Gastroparesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetic Gastroparesis Revenue
3.4 Global Diabetic Gastroparesis Market Concentration Ratio
3.4.1 Global Diabetic Gastroparesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Gastroparesis Revenue in 2024
3.5 Global Key Players of Diabetic Gastroparesis Head office and Area Served
3.6 Global Key Players of Diabetic Gastroparesis, Product and Application
3.7 Global Key Players of Diabetic Gastroparesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Gastroparesis Breakdown Data by Type
4.1 Global Diabetic Gastroparesis Historic Market Size by Type (2020-2025)
4.2 Global Diabetic Gastroparesis Forecasted Market Size by Type (2026-2031)
5 Diabetic Gastroparesis Breakdown Data by Application
5.1 Global Diabetic Gastroparesis Historic Market Size by Application (2020-2025)
5.2 Global Diabetic Gastroparesis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diabetic Gastroparesis Market Size (2020-2031)
6.2 North America Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diabetic Gastroparesis Market Size by Country (2020-2025)
6.4 North America Diabetic Gastroparesis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetic Gastroparesis Market Size (2020-2031)
7.2 Europe Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diabetic Gastroparesis Market Size by Country (2020-2025)
7.4 Europe Diabetic Gastroparesis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Gastroparesis Market Size (2020-2031)
8.2 Asia-Pacific Diabetic Gastroparesis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2020-2025)
8.4 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetic Gastroparesis Market Size (2020-2031)
9.2 Latin America Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diabetic Gastroparesis Market Size by Country (2020-2025)
9.4 Latin America Diabetic Gastroparesis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Gastroparesis Market Size (2020-2031)
10.2 Middle East & Africa Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2020-2025)
10.4 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetic Gastroparesis Introduction
11.1.4 Medtronic Revenue in Diabetic Gastroparesis Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Sumitomo Dainippon Pharma
11.2.1 Sumitomo Dainippon Pharma Company Details
11.2.2 Sumitomo Dainippon Pharma Business Overview
11.2.3 Sumitomo Dainippon Pharma Diabetic Gastroparesis Introduction
11.2.4 Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2020-2025)
11.2.5 Sumitomo Dainippon Pharma Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetic Gastroparesis Introduction
11.3.4 Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Details
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Diabetic Gastroparesis Introduction
11.4.4 Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2020-2025)
11.4.5 Boston Scientific Corporation Recent Development
11.5 C. R. Bard, Inc
11.5.1 C. R. Bard, Inc Company Details
11.5.2 C. R. Bard, Inc Business Overview
11.5.3 C. R. Bard, Inc Diabetic Gastroparesis Introduction
11.5.4 C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2020-2025)
11.5.5 C. R. Bard, Inc Recent Development
11.6 Janssen Global Services, LLC
11.6.1 Janssen Global Services, LLC Company Details
11.6.2 Janssen Global Services, LLC Business Overview
11.6.3 Janssen Global Services, LLC Diabetic Gastroparesis Introduction
11.6.4 Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2020-2025)
11.6.5 Janssen Global Services, LLC Recent Development
11.7 Alfasigma SpA
11.7.1 Alfasigma SpA Company Details
11.7.2 Alfasigma SpA Business Overview
11.7.3 Alfasigma SpA Diabetic Gastroparesis Introduction
11.7.4 Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2020-2025)
11.7.5 Alfasigma SpA Recent Development
11.8 Evoke Pharma
11.8.1 Evoke Pharma Company Details
11.8.2 Evoke Pharma Business Overview
11.8.3 Evoke Pharma Diabetic Gastroparesis Introduction
11.8.4 Evoke Pharma Revenue in Diabetic Gastroparesis Business (2020-2025)
11.8.5 Evoke Pharma Recent Development
11.9 Cadila Pharmaceuticals
11.9.1 Cadila Pharmaceuticals Company Details
11.9.2 Cadila Pharmaceuticals Business Overview
11.9.3 Cadila Pharmaceuticals Diabetic Gastroparesis Introduction
11.9.4 Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025)
11.9.5 Cadila Pharmaceuticals Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Diabetic Gastroparesis Introduction
11.10.4 Sanofi Revenue in Diabetic Gastroparesis Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Details
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2020-2025)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Diabetic Gastroparesis Introduction
11.12.4 Pfizer Revenue in Diabetic Gastroparesis Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Vanda Pharmaceuticals
11.13.1 Vanda Pharmaceuticals Company Details
11.13.2 Vanda Pharmaceuticals Business Overview
11.13.3 Vanda Pharmaceuticals Diabetic Gastroparesis Introduction
11.13.4 Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025)
11.13.5 Vanda Pharmaceuticals Recent Development
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Diabetic Gastroparesis Introduction
11.14.4 Allergan Revenue in Diabetic Gastroparesis Business (2020-2025)
11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Gastroparesis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Surgical Treatment Products
1.3 Market by Application
1.3.1 Global Diabetic Gastroparesis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Gastroparesis Market Perspective (2020-2031)
2.2 Global Diabetic Gastroparesis Growth Trends by Region
2.2.1 Global Diabetic Gastroparesis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diabetic Gastroparesis Historic Market Size by Region (2020-2025)
2.2.3 Diabetic Gastroparesis Forecasted Market Size by Region (2026-2031)
2.3 Diabetic Gastroparesis Market Dynamics
2.3.1 Diabetic Gastroparesis Industry Trends
2.3.2 Diabetic Gastroparesis Market Drivers
2.3.3 Diabetic Gastroparesis Market Challenges
2.3.4 Diabetic Gastroparesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Gastroparesis Players by Revenue
3.1.1 Global Top Diabetic Gastroparesis Players by Revenue (2020-2025)
3.1.2 Global Diabetic Gastroparesis Revenue Market Share by Players (2020-2025)
3.2 Global Diabetic Gastroparesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetic Gastroparesis Revenue
3.4 Global Diabetic Gastroparesis Market Concentration Ratio
3.4.1 Global Diabetic Gastroparesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Gastroparesis Revenue in 2024
3.5 Global Key Players of Diabetic Gastroparesis Head office and Area Served
3.6 Global Key Players of Diabetic Gastroparesis, Product and Application
3.7 Global Key Players of Diabetic Gastroparesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Gastroparesis Breakdown Data by Type
4.1 Global Diabetic Gastroparesis Historic Market Size by Type (2020-2025)
4.2 Global Diabetic Gastroparesis Forecasted Market Size by Type (2026-2031)
5 Diabetic Gastroparesis Breakdown Data by Application
5.1 Global Diabetic Gastroparesis Historic Market Size by Application (2020-2025)
5.2 Global Diabetic Gastroparesis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diabetic Gastroparesis Market Size (2020-2031)
6.2 North America Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diabetic Gastroparesis Market Size by Country (2020-2025)
6.4 North America Diabetic Gastroparesis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetic Gastroparesis Market Size (2020-2031)
7.2 Europe Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diabetic Gastroparesis Market Size by Country (2020-2025)
7.4 Europe Diabetic Gastroparesis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Gastroparesis Market Size (2020-2031)
8.2 Asia-Pacific Diabetic Gastroparesis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2020-2025)
8.4 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetic Gastroparesis Market Size (2020-2031)
9.2 Latin America Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diabetic Gastroparesis Market Size by Country (2020-2025)
9.4 Latin America Diabetic Gastroparesis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Gastroparesis Market Size (2020-2031)
10.2 Middle East & Africa Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2020-2025)
10.4 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetic Gastroparesis Introduction
11.1.4 Medtronic Revenue in Diabetic Gastroparesis Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Sumitomo Dainippon Pharma
11.2.1 Sumitomo Dainippon Pharma Company Details
11.2.2 Sumitomo Dainippon Pharma Business Overview
11.2.3 Sumitomo Dainippon Pharma Diabetic Gastroparesis Introduction
11.2.4 Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2020-2025)
11.2.5 Sumitomo Dainippon Pharma Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetic Gastroparesis Introduction
11.3.4 Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Details
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Diabetic Gastroparesis Introduction
11.4.4 Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2020-2025)
11.4.5 Boston Scientific Corporation Recent Development
11.5 C. R. Bard, Inc
11.5.1 C. R. Bard, Inc Company Details
11.5.2 C. R. Bard, Inc Business Overview
11.5.3 C. R. Bard, Inc Diabetic Gastroparesis Introduction
11.5.4 C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2020-2025)
11.5.5 C. R. Bard, Inc Recent Development
11.6 Janssen Global Services, LLC
11.6.1 Janssen Global Services, LLC Company Details
11.6.2 Janssen Global Services, LLC Business Overview
11.6.3 Janssen Global Services, LLC Diabetic Gastroparesis Introduction
11.6.4 Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2020-2025)
11.6.5 Janssen Global Services, LLC Recent Development
11.7 Alfasigma SpA
11.7.1 Alfasigma SpA Company Details
11.7.2 Alfasigma SpA Business Overview
11.7.3 Alfasigma SpA Diabetic Gastroparesis Introduction
11.7.4 Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2020-2025)
11.7.5 Alfasigma SpA Recent Development
11.8 Evoke Pharma
11.8.1 Evoke Pharma Company Details
11.8.2 Evoke Pharma Business Overview
11.8.3 Evoke Pharma Diabetic Gastroparesis Introduction
11.8.4 Evoke Pharma Revenue in Diabetic Gastroparesis Business (2020-2025)
11.8.5 Evoke Pharma Recent Development
11.9 Cadila Pharmaceuticals
11.9.1 Cadila Pharmaceuticals Company Details
11.9.2 Cadila Pharmaceuticals Business Overview
11.9.3 Cadila Pharmaceuticals Diabetic Gastroparesis Introduction
11.9.4 Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025)
11.9.5 Cadila Pharmaceuticals Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Diabetic Gastroparesis Introduction
11.10.4 Sanofi Revenue in Diabetic Gastroparesis Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Details
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2020-2025)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Diabetic Gastroparesis Introduction
11.12.4 Pfizer Revenue in Diabetic Gastroparesis Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Vanda Pharmaceuticals
11.13.1 Vanda Pharmaceuticals Company Details
11.13.2 Vanda Pharmaceuticals Business Overview
11.13.3 Vanda Pharmaceuticals Diabetic Gastroparesis Introduction
11.13.4 Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025)
11.13.5 Vanda Pharmaceuticals Recent Development
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Diabetic Gastroparesis Introduction
11.14.4 Allergan Revenue in Diabetic Gastroparesis Business (2020-2025)
11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diabetic Gastroparesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Surgical Treatment Products
Table 4. Global Diabetic Gastroparesis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Diabetic Gastroparesis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diabetic Gastroparesis Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Diabetic Gastroparesis Market Share by Region (2020-2025)
Table 8. Global Diabetic Gastroparesis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Diabetic Gastroparesis Market Share by Region (2026-2031)
Table 10. Diabetic Gastroparesis Market Trends
Table 11. Diabetic Gastroparesis Market Drivers
Table 12. Diabetic Gastroparesis Market Challenges
Table 13. Diabetic Gastroparesis Market Restraints
Table 14. Global Diabetic Gastroparesis Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Diabetic Gastroparesis Market Share by Players (2020-2025)
Table 16. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Gastroparesis as of 2024)
Table 17. Ranking of Global Top Diabetic Gastroparesis Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Diabetic Gastroparesis Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Diabetic Gastroparesis, Headquarters and Area Served
Table 20. Global Key Players of Diabetic Gastroparesis, Product and Application
Table 21. Global Key Players of Diabetic Gastroparesis, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Gastroparesis Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Diabetic Gastroparesis Revenue Market Share by Type (2020-2025)
Table 25. Global Diabetic Gastroparesis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Diabetic Gastroparesis Revenue Market Share by Type (2026-2031)
Table 27. Global Diabetic Gastroparesis Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Diabetic Gastroparesis Revenue Market Share by Application (2020-2025)
Table 29. Global Diabetic Gastroparesis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Diabetic Gastroparesis Revenue Market Share by Application (2026-2031)
Table 31. North America Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Diabetic Gastroparesis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Medtronic Company Details
Table 47. Medtronic Business Overview
Table 48. Medtronic Diabetic Gastroparesis Product
Table 49. Medtronic Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Sumitomo Dainippon Pharma Company Details
Table 52. Sumitomo Dainippon Pharma Business Overview
Table 53. Sumitomo Dainippon Pharma Diabetic Gastroparesis Product
Table 54. Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 55. Sumitomo Dainippon Pharma Recent Development
Table 56. Abbott Laboratories Company Details
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Diabetic Gastroparesis Product
Table 59. Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. Boston Scientific Corporation Company Details
Table 62. Boston Scientific Corporation Business Overview
Table 63. Boston Scientific Corporation Diabetic Gastroparesis Product
Table 64. Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 65. Boston Scientific Corporation Recent Development
Table 66. C. R. Bard, Inc Company Details
Table 67. C. R. Bard, Inc Business Overview
Table 68. C. R. Bard, Inc Diabetic Gastroparesis Product
Table 69. C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 70. C. R. Bard, Inc Recent Development
Table 71. Janssen Global Services, LLC Company Details
Table 72. Janssen Global Services, LLC Business Overview
Table 73. Janssen Global Services, LLC Diabetic Gastroparesis Product
Table 74. Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 75. Janssen Global Services, LLC Recent Development
Table 76. Alfasigma SpA Company Details
Table 77. Alfasigma SpA Business Overview
Table 78. Alfasigma SpA Diabetic Gastroparesis Product
Table 79. Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 80. Alfasigma SpA Recent Development
Table 81. Evoke Pharma Company Details
Table 82. Evoke Pharma Business Overview
Table 83. Evoke Pharma Diabetic Gastroparesis Product
Table 84. Evoke Pharma Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 85. Evoke Pharma Recent Development
Table 86. Cadila Pharmaceuticals Company Details
Table 87. Cadila Pharmaceuticals Business Overview
Table 88. Cadila Pharmaceuticals Diabetic Gastroparesis Product
Table 89. Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 90. Cadila Pharmaceuticals Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Diabetic Gastroparesis Product
Table 94. Sanofi Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Teva Pharmaceutical Industries Ltd Company Details
Table 97. Teva Pharmaceutical Industries Ltd Business Overview
Table 98. Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Product
Table 99. Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 100. Teva Pharmaceutical Industries Ltd Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Diabetic Gastroparesis Product
Table 104. Pfizer Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Vanda Pharmaceuticals Company Details
Table 107. Vanda Pharmaceuticals Business Overview
Table 108. Vanda Pharmaceuticals Diabetic Gastroparesis Product
Table 109. Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 110. Vanda Pharmaceuticals Recent Development
Table 111. Allergan Company Details
Table 112. Allergan Business Overview
Table 113. Allergan Diabetic Gastroparesis Product
Table 114. Allergan Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Diabetic Gastroparesis Picture
Figure 2. Global Diabetic Gastroparesis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diabetic Gastroparesis Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Surgical Treatment Products Features
Figure 6. Global Diabetic Gastroparesis Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Diabetic Gastroparesis Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Diabetic Gastroparesis Report Years Considered
Figure 12. Global Diabetic Gastroparesis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diabetic Gastroparesis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diabetic Gastroparesis Market Share by Region: 2024 VS 2031
Figure 15. Global Diabetic Gastroparesis Market Share by Players in 2024
Figure 16. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Gastroparesis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diabetic Gastroparesis Revenue in 2024
Figure 18. North America Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 20. United States Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 24. Germany Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diabetic Gastroparesis Market Share by Region (2020-2031)
Figure 32. China Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 40. Mexico Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 44. Turkey Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Medtronic Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 48. Sumitomo Dainippon Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 49. Abbott Laboratories Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 50. Boston Scientific Corporation Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 51. C. R. Bard, Inc Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 52. Janssen Global Services, LLC Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 53. Alfasigma SpA Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 54. Evoke Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 55. Cadila Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 57. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 59. Vanda Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 60. Allergan Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Diabetic Gastroparesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Surgical Treatment Products
Table 4. Global Diabetic Gastroparesis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Diabetic Gastroparesis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diabetic Gastroparesis Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Diabetic Gastroparesis Market Share by Region (2020-2025)
Table 8. Global Diabetic Gastroparesis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Diabetic Gastroparesis Market Share by Region (2026-2031)
Table 10. Diabetic Gastroparesis Market Trends
Table 11. Diabetic Gastroparesis Market Drivers
Table 12. Diabetic Gastroparesis Market Challenges
Table 13. Diabetic Gastroparesis Market Restraints
Table 14. Global Diabetic Gastroparesis Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Diabetic Gastroparesis Market Share by Players (2020-2025)
Table 16. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Gastroparesis as of 2024)
Table 17. Ranking of Global Top Diabetic Gastroparesis Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Diabetic Gastroparesis Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Diabetic Gastroparesis, Headquarters and Area Served
Table 20. Global Key Players of Diabetic Gastroparesis, Product and Application
Table 21. Global Key Players of Diabetic Gastroparesis, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Gastroparesis Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Diabetic Gastroparesis Revenue Market Share by Type (2020-2025)
Table 25. Global Diabetic Gastroparesis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Diabetic Gastroparesis Revenue Market Share by Type (2026-2031)
Table 27. Global Diabetic Gastroparesis Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Diabetic Gastroparesis Revenue Market Share by Application (2020-2025)
Table 29. Global Diabetic Gastroparesis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Diabetic Gastroparesis Revenue Market Share by Application (2026-2031)
Table 31. North America Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Diabetic Gastroparesis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Medtronic Company Details
Table 47. Medtronic Business Overview
Table 48. Medtronic Diabetic Gastroparesis Product
Table 49. Medtronic Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Sumitomo Dainippon Pharma Company Details
Table 52. Sumitomo Dainippon Pharma Business Overview
Table 53. Sumitomo Dainippon Pharma Diabetic Gastroparesis Product
Table 54. Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 55. Sumitomo Dainippon Pharma Recent Development
Table 56. Abbott Laboratories Company Details
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Diabetic Gastroparesis Product
Table 59. Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. Boston Scientific Corporation Company Details
Table 62. Boston Scientific Corporation Business Overview
Table 63. Boston Scientific Corporation Diabetic Gastroparesis Product
Table 64. Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 65. Boston Scientific Corporation Recent Development
Table 66. C. R. Bard, Inc Company Details
Table 67. C. R. Bard, Inc Business Overview
Table 68. C. R. Bard, Inc Diabetic Gastroparesis Product
Table 69. C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 70. C. R. Bard, Inc Recent Development
Table 71. Janssen Global Services, LLC Company Details
Table 72. Janssen Global Services, LLC Business Overview
Table 73. Janssen Global Services, LLC Diabetic Gastroparesis Product
Table 74. Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 75. Janssen Global Services, LLC Recent Development
Table 76. Alfasigma SpA Company Details
Table 77. Alfasigma SpA Business Overview
Table 78. Alfasigma SpA Diabetic Gastroparesis Product
Table 79. Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 80. Alfasigma SpA Recent Development
Table 81. Evoke Pharma Company Details
Table 82. Evoke Pharma Business Overview
Table 83. Evoke Pharma Diabetic Gastroparesis Product
Table 84. Evoke Pharma Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 85. Evoke Pharma Recent Development
Table 86. Cadila Pharmaceuticals Company Details
Table 87. Cadila Pharmaceuticals Business Overview
Table 88. Cadila Pharmaceuticals Diabetic Gastroparesis Product
Table 89. Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 90. Cadila Pharmaceuticals Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Diabetic Gastroparesis Product
Table 94. Sanofi Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Teva Pharmaceutical Industries Ltd Company Details
Table 97. Teva Pharmaceutical Industries Ltd Business Overview
Table 98. Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Product
Table 99. Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 100. Teva Pharmaceutical Industries Ltd Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Diabetic Gastroparesis Product
Table 104. Pfizer Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Vanda Pharmaceuticals Company Details
Table 107. Vanda Pharmaceuticals Business Overview
Table 108. Vanda Pharmaceuticals Diabetic Gastroparesis Product
Table 109. Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 110. Vanda Pharmaceuticals Recent Development
Table 111. Allergan Company Details
Table 112. Allergan Business Overview
Table 113. Allergan Diabetic Gastroparesis Product
Table 114. Allergan Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Diabetic Gastroparesis Picture
Figure 2. Global Diabetic Gastroparesis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diabetic Gastroparesis Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Surgical Treatment Products Features
Figure 6. Global Diabetic Gastroparesis Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Diabetic Gastroparesis Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Diabetic Gastroparesis Report Years Considered
Figure 12. Global Diabetic Gastroparesis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diabetic Gastroparesis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diabetic Gastroparesis Market Share by Region: 2024 VS 2031
Figure 15. Global Diabetic Gastroparesis Market Share by Players in 2024
Figure 16. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Gastroparesis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diabetic Gastroparesis Revenue in 2024
Figure 18. North America Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 20. United States Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 24. Germany Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diabetic Gastroparesis Market Share by Region (2020-2031)
Figure 32. China Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 40. Mexico Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diabetic Gastroparesis Market Share by Country (2020-2031)
Figure 44. Turkey Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Medtronic Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 48. Sumitomo Dainippon Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 49. Abbott Laboratories Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 50. Boston Scientific Corporation Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 51. C. R. Bard, Inc Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 52. Janssen Global Services, LLC Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 53. Alfasigma SpA Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 54. Evoke Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 55. Cadila Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 57. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 59. Vanda Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 60. Allergan Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232